UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2002-01, Vol.94 (2), p.116-128

2002

Volltextzugriff (PDF)

Age as prognostic factor in premenopausal breast carcinoma

The Lancet (British edition), 1993-04, Vol.341 (8852), p.1039-1043

1993

Volltextzugriff (PDF)

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction

Clinical cancer research, 2000-08, Vol.6 (8), p.3117-3122

2000

Volltextzugriff (PDF)

p53 Mutation as a Genetic Trait of Typical Medullary Breast Carcinoma

JNCI : Journal of the National Cancer Institute, 1999-04, Vol.91 (7), p.641-643

1999

Volltextzugriff (PDF)

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

British journal of cancer, 1996-06, Vol.73 (12), p.1545-1551

1996

Volltextzugriff (PDF)

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

British journal of cancer, 2003-08, Vol.89 (3), p.539-545

2003

Volltextzugriff (PDF)

Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

Clinical cancer research, 2004-02, Vol.10 (4), p.1392-1400

2004

Volltextzugriff (PDF)

Low expression of bcl-2 in Brca1-associated breast cancers

British journal of cancer, 2000-11, Vol.83 (10), p.1318-1322

2000

Volltextzugriff (PDF)

Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations

Journal of clinical oncology, 2000-12, Vol.18 (24), p.4053-4059

2000

Volltextzugriff (PDF)

Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy

JNCI : Journal of the National Cancer Institute, 1989-09, Vol.81 (18), p.1383-1387

1989

Volltextzugriff (PDF)

A new member of the ETS family fused to EWS in Ewing tumors

Oncogene, 1997-03, Vol.14 (10), p.1159-1164

1997

Volltextzugriff (PDF)

Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast

Histopathology, 2004-08, Vol.45 (2), p.142-147

2004

Volltextzugriff (PDF)

Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer

Breast cancer research and treatment, 1996-01, Vol.37 (1), p.57-64

1996

Volltextzugriff (PDF)

Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph‐node metastasis

International journal of cancer, 1992-02, Vol.50 (4), p.533-538

1992

Volltextzugriff (PDF)

Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy

Clinical cancer research, 1997-12, Vol.3 (12), p.2471-2478

1997

Volltextzugriff (PDF)

Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer

British journal of cancer, 1994-02, Vol.69 (2), p.342-346

1994

Volltextzugriff (PDF)

Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations

British journal of cancer, 1998-11, Vol.78 (9), p.1214-1218

1998

Volltextzugriff (PDF)

Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line

Oncogene, 2004-03, Vol.23 (9), p.1737-1744

2004

Volltextzugriff (PDF)

Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation

British journal of cancer, 1991-09, Vol.64 (3), p.501-507

1991

Volltextzugriff (PDF)

Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer

International journal of cancer, 1994-04, Vol.57 (1), p.63-66

1994

Volltextzugriff (PDF)

Visualizing chromosomes as transcriptome correlation maps: Evidence of chromosomal domains containing co-expressed genes: A study of 130 invasive ductal breast carcinomas

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (4), p.1376-1383

2005

Volltextzugriff (PDF)

Real‐time quantitative PCR determination of urokinase‐type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients

International journal of cancer, 2005-03, Vol.114 (2), p.291-298

2005

Volltextzugriff (PDF)

Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer

British journal of cancer, 1997-01, Vol.76 (4), p.537-540

1997

Volltextzugriff (PDF)

S-phase fractions of breast cancer predict overall and post-relapse survival

European journal of cancer (1990), 1997-04, Vol.33 (4), p.581-586

1997

Volltextzugriff (PDF)

Efficiency of the Hybrid Capture 2 HPV DNA test in cervical cancer screening: A study by the French Society of Clinical Cytology

American journal of clinical pathology, 2003-10, Vol.120 (4), p.492-499

2003

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(51)
Tagungsberichte
(1)

Sprache

Englisch
(52)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Age as prognostic factor in premenopausal breast carcinoma

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction

p53 Mutation as a Genetic Trait of Typical Medullary Breast Carcinoma

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

Low expression of bcl-2 in Brca1-associated breast cancers

Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations

Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy

A new member of the ETS family fused to EWS in Ewing tumors

Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast

Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer

Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph‐node metastasis

Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy

Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer

Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations

Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line

Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation

Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer

Visualizing chromosomes as transcriptome correlation maps: Evidence of chromosomal domains containing co-expressed genes: A study of 130 invasive ductal breast carcinomas

Real‐time quantitative PCR determination of urokinase‐type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients

Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer

S-phase fractions of breast cancer predict overall and post-relapse survival

Efficiency of the Hybrid Capture 2 HPV DNA test in cervical cancer screening: A study by the French Society of Clinical Cytology

Aktive Filter

Suchergebnisse filtern